How does EVQLV understand and utilize AI?

Mar 10, 2020 | Blog | 0 comments

Daniel Gigante

AI or artificial intelligence is a term that gets thrown around constantly in the tech space. In our most recent discussion, Andrew Satz (CEO, EVQLV), covers what it means when a company says they’re leveraging AI, how EVQLV is utilizing AI, the different types of AI (hint: that “A” doesn’t always mean artificial), and perhaps most interestedly, how AI can make us more human.

Timestamps:

What does it mean when a company says they’re leveraging AI? [0:08]

How should it be understood when we say we’re using AI? [3:27]

What type of AI are we leveraging: [5:36]

Can AI make us MORE human?: [8:45]

← How We're EVQLVing Life Science Can AI make us more human? →

0 Comments

Submit a Comment Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

EVQLV, Manhattan BioSolutions Announce UB CAT Grant Award

by EVQLV | June 29, 2021 | Press Releases | 0 Comments

University at Buffalo Center for Advanced Technology in Big Data and Health Sciences New York City, New York Jun 29, 2021 (Issuewire.com) - EVQLV, an innovator in developing artificial intelligence to accelerate how biologic therapies reach patients, and...

NY Bio-Computation Startup EVQLV Closes Financing Round

by Alexander Sonneborn | February 8, 2021 | Press Releases | 0 Comments

NEW YORK, February 8, 2021 -- EVQLV, an innovator in developing artificial intelligence to accelerate how biologic therapies reach patients, today announced the closing of a funding round that will be used to advance the company’s R&D efforts, boost development...

EVQLV Welcomes Operations & Finance Lead Alexander Sonneborn

by EVQLV | February 1, 2021 | News | 0 Comments

NEW YORK, February 1, 2021 -- EVQLV is pleased to announce that Alexander Sonneborn has joined EVQLV to oversee company operations and finances. After an early career in the life sciences, Alexander transitioned to entrepreneurial activities in technology-based...

EVQLV Submits 1 Million Ab Initio Derived Sequences for Validation

by Alexander Sonneborn | January 12, 2021 | Press Releases | 0 Comments

NEW YORK, January 12, 2021 - EVQLV has submitted one million AI-generated sequences for independent laboratory validation in fulfillment of the second phase of a project with its collaborator. The first phase of the project consisted of 100 antibody sequences based...

Fully Automated Rabbit Humanization Project Initiated w/ U Buffalo

by Alexander Sonneborn | December 16, 2020 | Press Releases | 0 Comments

NEW YORK, December 16, 2020 -- EVQLV is eagerly anticipating the results from the second phase of their University at Buffalo rabbit-humanization collaboration. Starting with rabbit monoclonal antibodies, EVQLV is attempting to validate its fully-automated...